Since 2002, BioCrossroads has worked to catalyze innovation and collaboration within Indiana’s life sciences sector. The sector has grown at a remarkable pace and has generated billions of dollars in revenue for the state with $79 billion in economic impact in 2021. BioCrossroads plays a critical role by convening academic, philanthropic, and cross-sector employer partners, enhancing research development, and working to attract life sciences businesses, innovation, and talent to Indiana.  

This unique collaborative approach has proven to be successful in times of need. At the onset of the COVID-19 pandemic, BioCrossroads played a key role convening Indiana’s life science and healthcare partners troubleshoot COVID testing, vaccine development and deployment, and other needs for Indiana residents.  

The Richard M. Fairbanks Foundation has awarded $11.5 million to BioCrossroads since 2003 to advance the economic vitality of Indianapolis. 

Additional Posts

Success stories: Employers can play a vital role in helping their employees stop smoking

Alex Cohen is the Director of Learning and Evaluation for the Richard M. Fairbanks Foundation. Public policies like higher cigarette taxes and expanded access to evidence-based cessation treatment can help lower smoking rates in Indianapolis and across the state. But employers looking to help their employees quit and improve their health today have a number […]


The decline in Indiana’s infant mortality rate is encouraging, but we can’t stop here. Stakeholders across all sectors must play a role in significantly improving Hoosier health outcomes.